Last reviewed · How we verify

NCT05567549

Evaluation of Sarcopenia in Elderly at the Emergency Department

Status unknown Last updated 5 October 2022
What this trial tests

trial in Sarcopenia in 300 participants. Status unknown.

Timeline
10 October 2022
Primary endpoint
10 July 2023
10 September 2023

Quick facts

Lead sponsorEge University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date10 October 2022
Primary completion10 July 2023
Estimated completion10 September 2023
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Ege University

Who can join

65 and older, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate in elderly patients for the frequency of sarcopenia and its relationship with mortality in a university hospital. The main questions it aims to answer are; 1. What is the frequency of sarcopenia in elderly patients at emergency department? 2. Is sarcopenia associated with mortality in an elderly patient admitted to the emergency department?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05567549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing